Category Archives: Mikhail Blagosklonny

How Mikhail Blagosklonny Oncology Research has improved Cancer Treatment

Mikhail Blagosklonny is respected oncology expert who is based in New York. The scientist is appreciated for his research in aging and cancer. Mikhail Blagosklonny joined the Roswell Park Cancer Institute in 2009, and he has been serving it a professor of oncology. Mikhail schooled at the First Pavlov State Medical University of St. Petersburg, which awarded him an M.D in internal medicine and later Ph.D. in experimental medicine and cardiology. The New York Medical College appointed him to serve it as an associate professor in 2002. He was then hired by Ordway Research Institute to act as a senior scientist before moving to Roswell Park. The scientist has done a lot of significant work at the companies that he has served, and this has offered him sufficient experience. His primary fields of study include anti-aging, biogerontology, and cancer. Mikhail Blagosklonny’s work has also focused on targeted cancer therapies that do not have side effects to the human body.

Oncotarget appreciated the oncology expertise of Prof. Blagosklonny and hired him to serve as its editor-in-chief. He is also knowledgeable in cancer biology and therapy where he serves as an associate editor. The professor understands a lot about cell death and differentiation. He has researched to determine how cancer and aging can be affected by TOR signaling. The world recognized him for spearheading campaigns for the use of Rapamycin in curing different cancers and other life-threatening diseases. According to him, the unique properties of Rapamycin make it the best cure for the condition. Blagosklonny’s career is also focused on clinical investigation, cellular biology, and molecular biology. The studies that he has done have covered sections such as anticancer therapeutics, tumor suppressors, mitosis, apoptosis, ontogenesis, signal transduction, and ontogenesis.

As an editor and researcher, Mikhail has published articles that discuss aging hyperfunction theory. His work has covered different topics that include cyclotherapy and chemotherapeutic engineering. The professor’s peers appreciate him for his oncology expertise. His studies have made him believe that doctors can control aging and cancer by using Rapamycin. He has successfully written and published approximately 300 informative reviews, book chapters, and articles. Mikhail has had an opportunity to be an associate editor at organizations such as the American Journal of Pathology, International Journal of Cancer, and PLOS ONE. He has a passion for the medical research field, and this has enabled him to make significant strides in oncology. Blagosklonny’s respect and love for human life inspired him to take his current career path. He works hard to ensure that the world is disease free.

The professor has been acknowledged for his outstanding service to the Roswell Park Cancer Institute. The organization has offered him on an opportunity to share ideas with various oncology professionals on how cancer can be treated. Mikhail Blagosklonny has committed himself to developing therapies that can slow down aging to control cancer. He believes that aging is a significant factor that causes cancer since the condition mostly affects old people than the youth. His oncology research will have a positive impact on the world.